The impact of adjuvant chemotherapy timing on overall survival following colorectal cancer resection

European Journal of Surgical Oncology

Volumn 41, Issue 12, 2015, Pages 1636-1644

  Nachiappan, S ^a,c   Askari, A ^a,c   Mamidanna, R ^a,c   Munasinghe, A ^a,c   Currie, A ^a,c   Stebbing, J ^b,c   Faiz, O ^a,c  

^a ST MARK S HOSPITAL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Adjuvant; Chemotherapy; Colorectal neoplasms; Epidemiology; Postoperative period

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; COLON CANCER; COLORECTAL CANCER; COMORBIDITY; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PRIORITY JOURNAL; RECTUM CANCER; YOUNG ADULT; ADOLESCENT; CLINICAL TRIAL; COLON RESECTION; COLORECTAL NEOPLASMS; ENGLAND; EPIDEMIOLOGY; MORTALITY; MULTICENTER STUDY; POSTOPERATIVE CARE; PROCEDURES; SURVIVAL RATE; TIME FACTOR; TRENDS;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLORECTAL NEOPLASMS; ENGLAND; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE CARE; SURVIVAL RATE; TIME FACTORS; YOUNG ADULT;

EID: 84950308436     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2015.09.009     Document Type: Article

References (20)

1. Cancer Research UK. Bowel cancer incidence statistics. Available from: http://www.cancerresearchuk.org/cancer-info/cancerstats/types/bowel/incidence/uk-bowel-cancer-incidence-statistics.
2. S.E. Tevis, B.M. Kohlnhofer, S. Stringfield, and et al. Postoperative complications in patients with rectal cancer are associated with delays in chemotherapy that lead to worse disease-free and overall survival Dis Colon Rectum 56 12 2013 1339 1348 10.1097/DCR.0b013e3182a857eb
3. S. Bayraktar, U.D. Bayraktar, and C.M. Rocha-Lima Timing of adjuvant and neoadjuvant therapy in colorectal cancers Clin Colorectal Cancer 9 3 2010 144 149 10.3816/CCC.2010.n.019
4. A. Mirnezami, R. Mirnezami, K. Chandrakumaran, K. Sasapu, P. Sagar, and P. Finan Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis Ann Surg 253 5 2011 890 899 10.1097/SLA.0b013e3182128929
5. J.J. Biagi, M.J. Raphael, W.J. Mackillop, W. Kong, W.D. King, and C.M. Booth Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis JAMA 305 22 2011 2335 2342 10.1001/jama.2011.749
6. L.G.M. Van der Geest, J.E.A. Portielje, M.W.J.M. Wouters, and et al. Complicated postoperative recovery increases omission, delay and discontinuation of adjuvant chemotherapy in patients with stage III colon cancer Colorectal Dis 15 10 2013 e582 e591 10.1111/codi.12288
7. S. Hendren, J.D. Birkmeyer, H. Yin, M. Banerjee, C. Sonnenday, and A.M. Morris Surgical complications are associated with omission of chemotherapy for stage III colorectal cancer Dis Colon Rectum 53 12 2010 1587 1593 10.1007/DCR.0b013e3181f2f202
8. O. Faiz, J. Warusavitarne, a Bottle, P.P. Tekkis, a W. Darzi, and R.H. Kennedy Laparoscopically assisted vs. open elective colonic and rectal resection: a comparison of outcomes in English National Health Service Trusts between 1996 and 2006 Dis Colon Rectum 52 10 2009 1695 1704 10.1007/DCR.0b013e3181b55254
9. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 5 1987 373 383
10. E. Von Elm, D.G. Altman, M. Egger, S.J. Pocock, P.C. Gøtzsche, and J.P. Vandenbroucke The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies J Clin Epidemiol 61 4 2008 344 349 10.1016/j.jclinepi.2007.11.008
11. G. Des Guetz, P. Nicolas, G.-Y. Perret, J.-F. Morere, and B. Uzzan Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis Eur J Cancer 46 6 2010 1049 1055 10.1016/j.ejca.2010.01.020
12. D.J. Kerr, R. Gray, C. McConkey, and J. Barnwell Adjuvant chemotherapy with 5-fluorouracil, L-folinic acid and levamisole for patients with colorectal cancer: non-randomised comparison of weekly versus four-weekly schedules-less pain, same gain. QUASAR Colorectal Cancer Study Group Ann Oncol 11 8 2000 947 955
13. T. André, C. Boni, M. Navarro, and et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial J Clin Oncol 27 19 2009 3109 3116 10.1200/JCO.2008.20.6771
14. R.P. Merkow, D.J. Bentrem, M.F. Mulcahy, and et al. Effect of postoperative complications on adjuvant chemotherapy use for stage III colon cancer Ann Surg 258 6 2013 847 853 10.1097/SLA.0000000000000312
15. P.M. Czaykowski, S. Gill, H.F. Kennecke, V.L. Gordon, and D. Turner Adjuvant chemotherapy for stage III colon cancer: does timing matter? Dis Colon Rectum 54 9 2011 1082 1089 10.1097/DCR.0b013e318223c3d6
16. Ahmad I., Anan G., Alvi R., et al. Impact of timing of initiation of adjuvant chemotherapy on survival after resection of colorectal cancer. Proc Am Soc Clin Oncol n.d;(Suppl. 77s):p. 18.
17. E.M. Burns, a. Bottle, P. Aylin, a. Darzi, R.J. Nicholls, and O. Faiz Variation in reoperation after colorectal surgery in England as an indicator of surgical performance: retrospective analysis of hospital episode statistics BMJ 343 1 Aug 16 2011 d4836 10.1136/bmj.d4836
18. A.B. Benson, D. Schrag, M.R. Somerfield, and et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer J Clin Oncol 22 16 2004 3408 3419 10.1200/JCO.2004.05.063
19. A. Figueredo, M.L. Charette, J. Maroun, M.C. Brouwers, and L. Zuraw Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group J Clin Oncol 22 16 2004 3395 3407 10.1200/JCO.2004.03.087
20. E.S. O'Connor, D.Y. Greenblatt, N.K. LoConte, and et al. Adjuvant chemotherapy for stage II colon cancer with poor prognostic features J Clin Oncol 29 25 2011 3381 3388 10.1200/JCO.2010.34.3426